Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Mouse CD300b/LMIR5 Fc Chimera Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2580LM050
This item is not returnable.
View return policy
Description
The Recombinant Mouse CD300b/LMIR5 Fc Chimera Protein is derived from NS0. The Recombinant Mouse CD300b/LMIR5 Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 43.2 kDa (monomer) | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. | |
| Mouse myeloma cell line,NS0-derived mouse CD300b/LMIR5 protein, (N-terminus) Mouse CD300b (Ile18-Tyr157) Accession &Num; Q3U497 IEGRMDP Mouse IgG2A (Glu98-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Yes |
| 217304 | |
| CD300b/LMIR5 Fc Chimera | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title